| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/25/2012 | CN102327385A Chinese herbal medicine for treating rheumatoid arthritis |
| 01/25/2012 | CN102327380A Chinese medicinal composition for treating knee osteoarthritis |
| 01/25/2012 | CN102327339A Traditional Chinese medicine synovium inflammation-removing plaster for treating chronic gonarthromeningitis |
| 01/25/2012 | CN102327318A Application of rubescensine in preparation of drug for preventing and treating osteoporosis |
| 01/25/2012 | CN102327308A Smokeless moxibustion stick, preparation method thereof and quality control method |
| 01/25/2012 | CN102327301A Application of Japanese alder to preparation of medicaments for preventing and treating osteoporosis |
| 01/25/2012 | CN102327279A Triptolide and lonicerin compatible medicine composition, preparation and application thereof |
| 01/25/2012 | CN102327267A Pharmaceutical compositions |
| 01/25/2012 | CN102327239A Salmon calcitonin nano liposome injection and preparation method thereof |
| 01/25/2012 | CN102327216A Limaprost nanoemulsion preparation for vertebral canal injection of antisternum |
| 01/25/2012 | CN102327017A Medical pillow internally containing pure traditional Chinese medicines for treating cervical spondylosis and preparation method thereof |
| 01/25/2012 | CN102113984B Composition with function of reducing weight of abdomen |
| 01/25/2012 | CN102058717B Chinese medicine for treating femoral head necrosis |
| 01/25/2012 | CN102058690B Plaster for treating traumatic fracture, soft tissue injury and strain neck, shoulder, waist and leg pains |
| 01/25/2012 | CN102028810B Traditional Chinese medicine for treating lumbar intervertebral disc protrusion |
| 01/25/2012 | CN101991736B Medicament for treating osteopathy |
| 01/25/2012 | CN101972453B Chinese medicinal liquor for treating rheumatic and rheumatoid arthritis and preparation method thereof |
| 01/25/2012 | CN101954045B Traditional Chinese medicinal composition for treating damp arthralgia and preparation method thereof |
| 01/25/2012 | CN101897822B Traditional Chinese medicinal preparation for treating hyperosteogeny and prolapse of intervertebral discs and preparation method thereof |
| 01/25/2012 | CN101804158B Paste for traumatic injuries |
| 01/25/2012 | CN101747414B Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
| 01/25/2012 | CN101732648B Medicament for treating nonunion |
| 01/25/2012 | CN101703751B Emplastrum for treating white-plus disease and preparation method thereof |
| 01/25/2012 | CN101703484B Preparation method of hexadecadrol sodium phosphate freeze-dried powder injection |
| 01/25/2012 | CN101569738B Plaster for treating mastitis, hyperplasia of mammary glands, breast lumps, hydrarthrosis, traumatic injury, preparation method and application thereof |
| 01/25/2012 | CN101491570B Composite preparation for treating cervical spondylosis and preparation method thereof |
| 01/25/2012 | CN101380414B Traditional Chinese medicine composition for treating gout and hyperuricemia and preparation method thereof |
| 01/25/2012 | CN101255197B Fusion protein for serum albumin and interleukin 1 receptor antagonist and uses thereof |
| 01/25/2012 | CN101085813B Soluble TNF acceptor mutant |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101793 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 01/24/2012 | US8101751 Reverse-turn mimetics and method relating thereto |
| 01/24/2012 | US8101650 Method for treating a immunology-related disease |
| 01/24/2012 | US8101612 N-3-isoxazolyl-4-methyl-3-(1-((1-methylethyl)oxy)-6-phthalazinyl)benzamide; p38 kinase inhibitor; antiinflammatory, analgesic agent; rheumatoid arthritis, osteoporosis, leukemia, psoriasis, Crohn's disease, rhinitis, ulcerative colitis, dermatitis, asthma, Alzheimer's disease, type I and II diabetes |
| 01/24/2012 | US8101381 Human cytokine receptor |
| 01/24/2012 | CA2656216C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 01/24/2012 | CA2522594C Mitotic kinesin inhibitor |
| 01/24/2012 | CA2520436C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 01/24/2012 | CA2498559C Indole derivatives or benzimidazole derivatives for modulating i.kappa.b kinase |
| 01/24/2012 | CA2480567C Mixed-cell gene therapy |
| 01/24/2012 | CA2470230C Pharmaceutical formulation comprising cyclosporin and use thereof |
| 01/24/2012 | CA2459577C An enantiomerically pure opioid diarylmethylpiperazine and methods of using same |
| 01/24/2012 | CA2455483C The use of trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl derivatives in the treatment and/or prophylaxis of obesity and its concomitant and/or secondary diseases |
| 01/24/2012 | CA2455227C Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 01/24/2012 | CA2435687C Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 01/24/2012 | CA2431196C Black tea extract for prevention of disease |
| 01/24/2012 | CA2402092C 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 01/19/2012 | WO2012009705A1 Ang-2 binding complexes and uses thereof |
| 01/19/2012 | WO2012009262A2 Diclofenac salt of tramadol |
| 01/19/2012 | WO2012008674A1 Anti-angiogenic composition containing macrolactin a and a derivative thereof as active ingredients |
| 01/19/2012 | WO2012008549A1 Heterocyclic ring compound |
| 01/19/2012 | WO2012008467A1 Pharmaceutical composition for promoting osteogenesis containing axial-equatorial aryl-oriented furofuran-type lignan, and pharmaceutical preparation, functional food product, and health food product comprising composition |
| 01/19/2012 | WO2012008457A1 Composition for external application |
| 01/19/2012 | WO2012007777A1 Novel proteins, process for preparation thereof, and use thereof |
| 01/19/2012 | WO2012007632A1 Use of edg2 inhibitors for treating rheumatoid arthritis |
| 01/19/2012 | WO2012007451A1 Crystalline compound of 1-[4-(2-azepan-1-ylethoxy)benzyl]-2-(4-hydroxyphenyl)-3-methyl-1h-indol-5-ol and lactic acid |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2012006864A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 01/19/2012 | WO2011136469A3 Pharmaceutical composition using connective tissue growth factor |
| 01/19/2012 | WO2011109551A3 Compounds that modulate intracellular calcium |
| 01/19/2012 | WO2011102684A3 Composition containing placenta extracts |
| 01/19/2012 | US20120016489 Textured bone block implants |
| 01/19/2012 | US20120016475 Degradable composite |
| 01/19/2012 | US20120016035 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/19/2012 | US20120016020 Solid dispersion of alpha-ketoamide derivatives |
| 01/19/2012 | US20120016005 Phagocytic cell delivery of rnai |
| 01/19/2012 | US20120015999 Formulations of (r)-1-(2,2-difluorobenzo[d] [1,3] dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl)cyclopropanecarboxamide |
| 01/19/2012 | US20120015992 Napthalene-Based Inhibitors of Anti-Apoptotic Proteins |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015985 Methods of Administering Pirfenidone Therapy |
| 01/19/2012 | US20120015984 Granulate Formulation of Pirfenidone and Pharmaceutically Acceptable Excipients |
| 01/19/2012 | US20120015982 Thiazolidinedione analogues |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015976 Autotaxin inhibitors |
| 01/19/2012 | US20120015972 Indolizine derivative and use thereof for medical purposes |
| 01/19/2012 | US20120015963 NOVEL PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS |
| 01/19/2012 | US20120015962 PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS |
| 01/19/2012 | US20120015957 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 01/19/2012 | US20120015933 Spirocyclic nitriles as protease inhibitors |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015928 Amido Compounds And Their Use As Pharmaceuticals |
| 01/19/2012 | US20120015927 Crystalline forms of n-[2-[[(2,3-difluorophenyl)methyl]thio]-6--4-pyrimidinyl]-1-azetidinesulfonamide |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015915 Formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | US20120015914 Formulations of 14-epi-analogues of vitamin d |
| 01/19/2012 | US20120015913 Formulations of 14-EPI-Analogues of Vitamin D |
| 01/19/2012 | US20120015903 PHARMACEUTICAL COMPOSITION FOR INHIBITING INCREASE OF IgA |
| 01/19/2012 | US20120015051 Chlorite Formulations and Methods of Preparation and Use Thereof |
| 01/19/2012 | US20120015047 Choline-silicic acid complex with osmolytes and divalent trace elements |
| 01/19/2012 | US20120015029 Direct compression formulation and process |
| 01/19/2012 | US20120015024 Methods for treating tweak-related conditions |
| 01/19/2012 | US20120015003 Layered Scaffold Suitable for Osteochondral Repair |
| 01/19/2012 | US20120014997 Aryl sulfonamides |
| 01/19/2012 | US20120014991 Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| 01/19/2012 | US20120014989 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS |
| 01/19/2012 | US20120014979 Use of bcl6 inhibitors for treating autoimmune diseases |
| 01/19/2012 | US20120014966 Methods for the treatment of il-1beta related conditions |
| 01/19/2012 | US20120014959 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |